JP2002538110A5 - - Google Patents

Download PDF

Info

Publication number
JP2002538110A5
JP2002538110A5 JP2000602059A JP2000602059A JP2002538110A5 JP 2002538110 A5 JP2002538110 A5 JP 2002538110A5 JP 2000602059 A JP2000602059 A JP 2000602059A JP 2000602059 A JP2000602059 A JP 2000602059A JP 2002538110 A5 JP2002538110 A5 JP 2002538110A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
dispersion
dry powder
pharmaceutically acceptable
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000602059A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538110A (ja
Filing date
Publication date
Priority claimed from GBGB9904919.9A external-priority patent/GB9904919D0/en
Application filed filed Critical
Publication of JP2002538110A publication Critical patent/JP2002538110A/ja
Publication of JP2002538110A5 publication Critical patent/JP2002538110A5/ja
Withdrawn legal-status Critical Current

Links

JP2000602059A 1999-03-03 2000-03-01 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ Withdrawn JP2002538110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9904919.9 1999-03-03
GBGB9904919.9A GB9904919D0 (en) 1999-03-03 1999-03-03 Organic compounds
PCT/EP2000/001722 WO2000051591A1 (en) 1999-03-03 2000-03-01 Combinations of formoterol and mometasone furoate for asthma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009174025A Division JP5646828B2 (ja) 1999-03-03 2009-07-27 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ

Publications (2)

Publication Number Publication Date
JP2002538110A JP2002538110A (ja) 2002-11-12
JP2002538110A5 true JP2002538110A5 (enExample) 2008-05-01

Family

ID=10848904

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000602059A Withdrawn JP2002538110A (ja) 1999-03-03 2000-03-01 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
JP2009174025A Expired - Lifetime JP5646828B2 (ja) 1999-03-03 2009-07-27 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
JP2013010543A Expired - Lifetime JP5663046B2 (ja) 1999-03-03 2013-01-23 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009174025A Expired - Lifetime JP5646828B2 (ja) 1999-03-03 2009-07-27 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
JP2013010543A Expired - Lifetime JP5663046B2 (ja) 1999-03-03 2013-01-23 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ

Country Status (27)

Country Link
US (4) US20020055494A1 (enExample)
EP (2) EP1156790B1 (enExample)
JP (3) JP2002538110A (enExample)
KR (1) KR100682418B1 (enExample)
CN (1) CN1196478C (enExample)
AT (1) ATE241970T1 (enExample)
AU (1) AU770739B2 (enExample)
BR (1) BR0008699A (enExample)
CA (1) CA2362499C (enExample)
CL (1) CL2004001170A1 (enExample)
CZ (1) CZ294089B6 (enExample)
DE (1) DE60003160T2 (enExample)
DK (1) DK1156790T3 (enExample)
ES (1) ES2200837T3 (enExample)
GB (1) GB9904919D0 (enExample)
HK (1) HK1043048B (enExample)
HU (1) HU229073B1 (enExample)
ID (1) ID30171A (enExample)
IL (1) IL144351A (enExample)
NO (1) NO331428B1 (enExample)
NZ (1) NZ513742A (enExample)
PL (1) PL212355B1 (enExample)
PT (1) PT1156790E (enExample)
RU (1) RU2270670C2 (enExample)
SK (1) SK286338B6 (enExample)
WO (1) WO2000051591A1 (enExample)
ZA (1) ZA200106442B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
EP1311294A2 (en) * 2000-08-04 2003-05-21 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
AU2003222753B2 (en) * 2002-03-01 2008-04-17 Chiesi Farmaceutici S.P.A. Formoterol superfine formulation
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ATE384001T1 (de) * 2002-08-27 2008-02-15 Schering Corp Verfahren zur herstellung von dosierinhalatorformulierungen
US20040043064A1 (en) * 2002-08-29 2004-03-04 Iorio Theodore L. Dosage forms having reduced moisture transmission
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
MXPA06003376A (es) * 2003-09-26 2006-06-08 Schering Corp Tratamiento de enfermedad pulmonar.
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
WO2005037245A2 (en) * 2003-10-21 2005-04-28 Direct-Haler A/S A multiple route medication for the treatment of rhinitis and asthma
MX2007012084A (es) * 2005-03-30 2007-11-21 Schering Corp Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada.
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20080319079A1 (en) * 2005-11-23 2008-12-25 Feanny Stephen J Method for Administering Formoterol Using a Nebulizer
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
US20080294720A1 (en) * 2007-05-21 2008-11-27 International Business Machines Corporation Enhanced Online Collaboration System
US8898316B2 (en) * 2007-05-30 2014-11-25 International Business Machines Corporation Enhanced online collaboration system for viewers of video presentations
EP3106149B1 (en) * 2009-05-29 2019-11-20 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta-2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011093815A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic Pharmaceutical compositions comprising formoterol and mometasone
WO2012028745A1 (en) * 2010-09-03 2012-03-08 Pharmaterials Limited Pharmaceutical composition suitable for use in a dry powder inhaler
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
GB201113662D0 (en) 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
US10111957B2 (en) * 2012-07-05 2018-10-30 Arven Ilac Snayi ve Ticaret A.S. Inhalation compositions comprising glucose anhydrous
WO2014007771A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising muscarinic receptor antagonist
BR112015022784B1 (pt) 2013-03-15 2023-02-14 Pearl Therapeutics, Inc Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
US9427376B2 (en) * 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
KR102449403B1 (ko) * 2014-10-08 2022-09-29 잠본쏘시에떼퍼아찌오니 부데소니드 및 포르모테롤을 함유하는 약학 조성물
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3701940B1 (en) 2015-12-04 2025-11-12 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CN115813935A (zh) * 2021-09-16 2023-03-21 上海上药信谊药厂有限公司 药物组合物、气雾剂及其制备方法和气雾剂产生系统
CN116763797B (zh) * 2022-03-09 2025-09-02 上海医药工业研究院有限公司 一种药物组合微球、其制备方法及其原料组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
CZ288032B6 (cs) 1991-12-18 2001-04-11 Aktiebolaget Astra Farmaceutický prostředek pro podání inhalací
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
JP4155594B2 (ja) 1994-12-22 2008-09-24 アストラゼネカ・アクチエボラーグ エアゾール製剤
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6461591B1 (en) * 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
EP0969816B1 (en) * 1997-03-20 2004-12-15 Schering Corporation Preparation of powder agglomerates
JP3676674B2 (ja) * 1997-10-09 2005-07-27 シェーリング コーポレイション 噴霧のためのモメタゾンフロエート懸濁液
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma

Similar Documents

Publication Publication Date Title
JP2002538110A5 (enExample)
RU2001126347A (ru) Композиции, включающие формотерол и фуроат мометасона, предназначенные для лечения астмы
RU2001123923A (ru) Композиции, включающие формотерол и соль тиотропия
JP5952231B2 (ja) ドラッグ・デリバリー用の安定な金属イオン−脂質粉末状医薬組成物とその利用方法
CN101181263B (zh) 呼吸系统疾病的治疗药物
EP0386232B1 (en) Nasal administration of benzodiazepine hypnotics
RU2002116251A (ru) Аэрозольная композиция, содержащая формотерол
RU2001124599A (ru) Комбинации формотерола и пропионата флутиказона для лечения астмы
JP2004514739A5 (enExample)
JP2002519318A5 (enExample)
CA2427282A1 (en) Mixtures or organic compounds for the treatment of airway diseases
SI9200403B (en) New combination of a bronchodilator and a steroidal antiinflammatory drug for treatment of respiratory disorders as well as its use and preparation thereof
JP2002528399A (ja) Δ９テトラヒドロカナビノール（δ９ｔｈｃ）溶液計量ずみ投与量吸入器および使用方法
BR0303348A (pt) Formulações de aerossol para administração pulmonar de medicamentos com o intuito de produzir efeito sistêmico
JP2005515966A5 (enExample)
KR970704422A (ko) 투여용 약제학적 조성물
CA2277365A1 (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
FI2265257T4 (fi) Aklidiniumia käsittävä inhalaatiokoostumus kroonisen keuhkoahtaumataudin hoitamiseksi
RU2008124825A (ru) Органические соединения, включающие соль гликопиррония
IE914498A1 (en) Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein
RU2005135133A (ru) Фармацевтические композиции
WO2002028368A1 (en) New combination for the treatment of asthma
JP2004529108A5 (enExample)
WO2004017942A8 (en) Inhalation compositions with high drug ratios
CA2701956A1 (en) Combination therapy